Is Catalent, Inc.'s (NYSE:CTLT) Recent Stock Performance Influenced By Its Fundamentals In Any Way?
Barclays Lowers Catalent (NYSE:CTLT) Price Target to $58.00
Catalent (NYSE:CTLT – Get Rating) had its price target cut by Barclays from $62.00 to $58.00 in a research note published on Tuesday, The Fly reports. They currently have an overweight rating on the
Catalent, Inc. to Post FY2023 Earnings of $2.95 Per Share, Jefferies Financial Group Forecasts (NYSE:CTLT)
Catalent, Inc. (NYSE:CTLT – Get Rating) – Analysts at Jefferies Financial Group increased their FY2023 earnings per share (EPS) estimates for Catalent in a report issued on Tuesday, January 24th.
Catalent (NYSE:CTLT) Price Target Cut to $58.00
Catalent (NYSE:CTLT – Get Rating) had its target price lowered by Barclays from $62.00 to $58.00 in a report released on Tuesday, The Fly reports. The brokerage currently has an "overweight" rating
Q2 2023 Earnings Estimate for Catalent, Inc. Issued By Jefferies Financial Group (NYSE:CTLT)
Catalent, Inc. (NYSE:CTLT – Get Rating) – Analysts at Jefferies Financial Group upped their Q2 2023 EPS estimates for shares of Catalent in a report released on Tuesday, January 24th. Jefferies Fi
Bank Julius Baer & Co. Ltd Zurich Reduces Stake in Catalent, Inc. (NYSE:CTLT)
Bank Julius Baer & Co. Ltd Zurich lowered its position in Catalent, Inc. (NYSE:CTLT – Get Rating) by 16.1% during the third quarter, according to the company in its most recent disclosure with the S
Catalent (NYSE:CTLT) Trading Down 4.1% on Analyst Downgrade
Catalent, Inc. (NYSE:CTLT – Get Rating)'s stock price was down 4.1% on Tuesday after Barclays lowered their price target on the stock from $62.00 to $58.00. Barclays currently has an overweight ratin
Catalent Launched New Service for End-to-End Supply Chain Case Management of Cell and Gene Therapies
Catalent, the leader in enabling the development and supply of better treatments for patients worldwide, today announced the launch of its new Case Management Service, which has been specifically desi
Barclays Adjusts Catalent's Price Target to $58 From $62, Maintains Overweight Rating
09:01 AM EST, 01/24/2023 (MT Newswires) -- Catalent (CTLT) has an average rating of Outperform and price targets ranging from $58 to $100, according to analysts polled by Capital IQ.
Catalent Is Maintained at Overweight by Barclays
Catalent Is Maintained at Overweight by Barclays
Loading...
No Stock Yet